Crown Laboratories (Crown) President and CEO Jeff Bedard tells us about the fully integrated global skin care company that is committed to providing scientific solutions for life-long healthy skin. By collaborating with industry experts, academia, and its customers, Crown develops and provides a diverse portfolio of cutting-edge skin care products.
How does your company help other businesses become more effective?
Focusing specifically on our Dallas-based Crown Aesthetics business unit, our aesthetics portfolio is comprised of ideal “gateway” products that draw new consumers to aesthetics practices. By offering this range of best-in-class skin care solutions, our practices satisfy their loyal patient base because our solutions actually work. Through constant innovation, we bring novel products that are backed by science to market, which adds credibility to the product, to Crown, and to our customers.
What differentiates your company from others in your industry?
Our commitment to technology, education, and delivering A+ customer service has always been our mantra. Our technology is rooted in science, we offer a superior education program, and our customer service is unmatched. We partner with our practices, and we are committed to their success. Our customers know they can depend upon us to make their patients happy and their practice successful.
What do you enjoy most about doing business in the Dallas Region?
The talent in the Dallas Region is incredible – our employees are passionate about driving growth and building a great culture rooted in Dallas. We are also able to recruit top talent from the local universities. Our team enjoys being in the heart of the City of Dallas, where we enjoy holding team-building events at local restaurants and spaces.
Why did you decide to become a DRC member?
The DRC provides us with an opportunity to become more involved in the community. As a global organization, it is important that Crown supports the economic development and policy formation that affect our people. Developing the people within our community so that they are prepared to enter the workforce and grow within their careers is important to Crown. The DRC allows us to have a seat at the table and to influence change. We all have a responsibility to protect the health of our future, and our DRC relationship is going to give us a platform to do just that.
How has your business changed in the past five years?
For more than 15 years, Crown was primarily focused on its Blue Lizard Australian Sunscreen franchise. From the start, we knew that to best serve our customers, it would be in our best interest to become fully integrated and have sole responsibility for the entire operation. With that investment came some steep challenges. In 2017, Crown was acquired by a private equity firm and at the time had roughly 125 employees. Since then, our business has completely transformed into what it is today – a global skin care company with a diverse portfolio of aesthetic, premium, and therapeutic skin care products. Today, we employ over 600 people around the globe. Our products boast incredible accolades:
- SkinPen is the first FDA-cleared microneedling device in the world.
- PanOxyl is the No. 1 best-selling acne wash in the U.S.
- Blue Lizard Australian Sunscreen’s Baby Formula is the No. 1 pediatrician-recommended sunscreen brand.
- Sarna Lotion is the No. 1 dermatologist-recommended topical anti-itch brand.
- StriVectin was one of the fastest-growing brands in prestige skin care in 2022 and is growing quickly at Specialty Retailers, like Ulta.
We are an innovative company focused on skin science for life. Our unyielding pursuit of delivering therapeutic excellence and enhanced patient outcomes is why we have become a leader in Dermatology and Aesthetics. We have been listed on the Inc. 5000 Fastest Growing Privately Held Companies List for nine years and have expanded our distribution to over 41 countries.